dipyrone has been researched along with Disease Exacerbation in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mateus, JE; Silva, CD; Teles, C; Vaio, T | 1 |
Hayashi, Y; Hirose, N; Katare, RG; Lee, GH; Maeda, H; Radhakrishnan, G; Rao, P; Sasaguri, S; Yamaguchi, T; Yamamoto, M | 1 |
2 other study(ies) available for dipyrone and Disease Exacerbation
Article | Year |
---|---|
Acute intermittent porphyria: analgesia can be dangerous.
Topics: Abdominal Pain; Anti-Inflammatory Agents, Non-Steroidal; Dipyrone; Disease Progression; Female; Glucose; Hemin; Humans; Hyponatremia; Infusions, Parenteral; Middle Aged; Muscle Weakness; Pain Management; Porphyria, Acute Intermittent; Treatment Outcome | 2019 |
Bilirubin oxidation provoked by nitric oxide radicals predicts the progression of acute cardiac allograft rejection.
Topics: Acute Disease; Animals; Bilirubin; Biomarkers; Blotting, Western; Dipyrone; Disease Models, Animal; Disease Progression; Free Radical Scavengers; Graft Rejection; Heart Transplantation; Heme Oxygenase-1; Immunohistochemistry; Myocardium; Nitric Oxide; Oxidation-Reduction; Prognosis; Rats; Transplantation, Homologous; Tyrosine | 2007 |